N-glycans: Phenotypic homology and structural differences between myocardial cells and induced pluripotent stem cell-derived cardiomyocytes

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Kawamura, Takuji ^a   Miyagawa, Shigeru ^a   Fukushima, Satsuki ^a   Yoshida, Akira ^a   Kashiyama, Noriyuki ^a   Kawamura, Ai ^a   Ito, Emiko ^a   Saito, Atsuhiro ^a   Maeda, Akira ^b   Eguchi, Hiroshi ^b   Toda, Koichi ^a   Lee, Jong Kook ^a   Miyagawa, Shuji ^b   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTIDINE PHOSPHATE N ACYLNEURAMINATE PHOSPHODIESTERASE; GLYCAN; HIGH MANNOSE N GLYCAN; N GLYCOLOYLNEURAMINIC ACID; SIALYL N GLYCAN; UNCLASSIFIED DRUG; POLYSACCHARIDE;

ADULT; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CELL DIFFERENTIATION; CELL SURFACE; CONTROLLED STUDY; HEART MUSCLE CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; ANIMAL; CELL LINE; CONFORMATION; CYTOLOGY; HEART MUSCLE; METABOLISM;

ANIMALS; CARBOHYDRATE CONFORMATION; CELL DIFFERENTIATION; CELL LINE; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCARDIUM; MYOCYTES, CARDIAC; POLYSACCHARIDES;

EID: 84910089170     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111064     Document Type: Article

References (32)

1. Gonzales C, Pedrazzini T (2009) Progenitor cell therapy for heart disease. Exp Cell Res 315:3077-3085.
2. Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet 378:704-712.
3. Yoshida Y, Yamanaka S (2010) Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration. Circulation 122:80-87.
4. Yoshida Y, Yamanaka S (2011) iPS cells: A source of cardiac regeneration. Journal of Molecular and Cellular Cardiology 50:327-332.
5. Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, et al. (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:S29-37.
6. Mercola M, Colas A, Willems E (2013) Induced pluripotent stem cells in cardiovascular drug discovery. Circ Res 112:534-548.
7. Sinnecker D, Goedel A, Laugwitz KL, Moretti A (2013) Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research. Circ Res 112:961-968.
8. Kamakura T, Makiyama T, Sasaki K, Yoshida Y, Wuriyanghai Y, et al. (2013) Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture. Circ J 77:1307-1314.
9. Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, et al. (2009) Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J 23:4168-4180.
10. Varki A (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3:97-130.
11. Haltiwanger RS, Lowe JB (2004) Role of glycosylation in development. Annu Rev Biochem 73:491-537.
12. Ohtsubo K, Marth JD (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126:855-867.
13. Surani MA (1979) Glycoprotein synthesis and inhibition of glycosylation by tunicamycin in preimplantation mouse embryos: compaction and trophoblast adhesion. Cell 18:217-227.
14. Akama TO, Nakagawa H, Sugihara K, Narisawa S, Ohyama C, et al. (2002) Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science 295:124-127.
15. Hato M, Nakagawa H, Kurogochi M, Akama TO, Marth JD, et al. (2006) Unusual N-glycan structures in alpha-mannosidase II/IIx double null embryos identified by a systematic glycomics approach based on two-dimensional LC mapping and matrix-dependent selective fragmentation method in MALDITOF/TOF mass spectrometry. Mol Cell Proteomics 5:2146-2157.
16. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, et al. (2007) Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129:123-134.
17. Kraushaar DC, Rai S, Condac E, Nairn A, Zhang S, et al. (2012) Heparan sulfate facilitates FGF and BMP signaling to drive mesoderm differentiation of mouse embryonic stem cells. J Biol Chem 287:22691-22700.
18. Amano M, Yamaguchi M, Takegawa Y, Yamashita T, Terashima M, et al. (2010) Threshold in stage-specific embryonic glycotypes uncovered by a full portrait of dynamic N-glycan expression during cell differentiation. Mol Cell Proteomics 9:523-537.
19. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S (2008) Generation of mouse induced pluripotent stem cells without viral vectors. Science 322:949-953.
20. Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, et al. (2012) Bioengineered myocardium derived from induced pluripotent stem cells improves cardiac function and attenuates cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med 1:430-437.
21. Yu T, Miyagawa S, Miki K, Saito A, Fukushima S, et al. (2013) In vivo differentiation of induced pluripotent stem cell-derived cardiomyocytes. Circ J 77:1297-1306.
22. Tohyama S, Hattori F, Sano M, Hishiki T, Nagahata Y, et al. (2013) Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12:127-137.
23. Takahashi N, Khoo KH, Suzuki N, Johnson JR, Lee YC (2001) N-glycan structures from the major glycoproteins of pigeon egg white: predominance of terminal Galalpha (1) Gal. J Biol Chem 276:23230-23239.
24. Takahashi N, Kato K (2003) GALAXY (Glycoanalysis by the Three Axes of MS and Chromatography): a Web Application that Assists Structural Analyses of NGlycans. Trends in Glycoscience and Glycotechnology 15 No. 84:235-251.
25. Yagi H, Takahashi N, Yamaguchi Y, Kimura N, Uchimura K, et al. (2005) Development of structural analysis of sulfated N-glycans by multidimensional high performance liquid chromatography mapping methods. Glycobiology 15:1051-1060.
26. Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA (2014) Emerging principles for the therapeutic exploitation of glycosylation. Science 343:1235681.
27. Varki A (2009) Multiple changes in sialic acid biology during human evolution. Glycoconj J 26:231-245.
28. Irie A, Koyama S, Kozutsumi Y, Kawasaki T, Suzuki A (1998) The molecular basis for the absence of N-glycolylneuraminic acid in humans. J Biol Chem 273:15866-15871.
29. Chou HH, Takematsu H, Diaz S, Iber J, Nickerson E, et al. (1998) A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci U S A 95:11751-11756.
30. Hasehira K, Tateno H, Onuma Y, Ito Y, Asashima M, et al. (2012) Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells. Mol Cell Proteomics 11:1913-1923.
31. Tateno H, Toyota M, Saito S, Onuma Y, Ito Y, et al. (2011) Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem 286:20345-20353.
32. Fujitani N, Furukawa J, Araki K, Fujioka T, Takegawa Y, et al. (2013) Total cellular glycomics allows characterizing cells and streamlining the discovery process for cellular biomarkers. Proc Natl Acad Sci U S A 110:2105-2110.